
Lenzetto
Lenzetto
Product Description
Lenzetto 1.53mg/spray transdermal spray is indicated for Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women (in women at least 6 months since last menses or surgical menopause, with or without a uterus).
The experience in treating women older than 65 years is limited.Directions
Available on request.Ingredients
Available on request.Product Details
Form:SprayFridge-line:NoMarketing Authorisation:PL-Available on RequestToxin:NoPOM:YesLegal Category:POMFiller:NoStorage Temperature:N/AManufacturer:N/A